A
Alliance Pharma PLC
LSE:APH
Alliance Pharma PLC
LSE:APH
Price:
33.1 GBX
-1.78%
Market Closed
Updated:
May 5, 2024
Alliance Pharma PLC
Cash from Financing Activities
|
Alliance Pharma PLC
Cash from Financing Activities Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Cash from Financing Activities
-£29.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Financing Activities
-£5.6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Financing Activities
-$6.6B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-8%
|
|
|
Indivior PLC
LSE:INDV
|
Cash from Financing Activities
-$46m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Financing Activities
-$337m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Financing Activities
£316.5m
|
CAGR 3-Years
39%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is Alliance Pharma PLC's Cash from Financing Activities?
Cash from Financing Activities
-29.6m
GBP
-29.6m
GBP
Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Cash from Financing Activities amounts to -29.6m GBP.
What is Alliance Pharma PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-5%
-5%
Over the last year, the Cash from Financing Activities growth was -87%. The average annual Cash from Financing Activities growth rates for Alliance Pharma PLC have been -5% over the past three years .
You don't have any saved screeners yet
